Article Text

Download PDFPDF
Palliative opioid use, palliative sedation and euthanasia: reaffirming the distinction
  1. Guy Schofield1,2,
  2. Idris Baker2,3,
  3. Rachel Bullock2,4,
  4. Hannah Clare2,
  5. Paul Clark2,5,
  6. Derek Willis2,6,
  7. Craig Gannon2,7,
  8. Rob George2,8
  1. 1 Centre for Ethics in Medicine, University of Bristol, Bristol, UK
  2. 2 Ethics Committee, Association for Palliative Medicine of Great Britain and Ireland, Southampton, UK
  3. 3 Swansea Bay University Health Board, Swansea, Wales
  4. 4 Palliative Medicine, Worcestershire Acute Hospitals NHS Trust, Worcester, UK
  5. 5 Rowcroft Hospice, Torquay, UK
  6. 6 Chester Medical School, University of Chester Faculty of Medicine, Dentistry and Life Sciences, Chester, UK
  7. 7 Princess Alice Hospice, Esher, UK
  8. 8 St Christopher’s Hospice, London, UK
  1. Correspondence to Dr Guy Schofield, University of Bristol Centre for Ethics in Medicine, Bristol BS8 2PS, UK; guy.schofield{at}bristol.ac.uk

Abstract

We read with interest the extended essay published from Riisfeldt and are encouraged by an empirical ethics article which attempts to ground theory and its claims in the real world. However, such attempts also have real-world consequences. We are concerned to read the paper’s conclusion that clinical evidence weakens the distinction between euthanasia and normal palliative care prescribing. This is important. Globally, the most significant barrier to adequate symptom control in people with life-limiting illness is poor access to opioid analgesia. Opiophobia makes clinicians reluctant to prescribe and their patients reluctant to take opioids that might provide significant improvements in quality of life. We argue that the evidence base for the safety of opioid prescribing is broader than that presented, restricting the search to palliative care literature produces significant bias as safety experience and literature for opioids and sedatives exists in many fields. This is not acknowledged in the synthesis presented. By considering additional evidence, we reject the need for agnosticism and reaffirm that palliative opioid prescribing is safe. Second, palliative sedation in a clinical context is a poorly defined concept covering multiple interventions and treatment intentions. We detail these and show that continuous deep palliative sedation (CDPS) is a specific practice that remains controversial globally and is not considered routine practice. Rejecting agnosticism towards opioids and excluding CDPS from the definition of routine care allows the rejection of Riisfeldt’s headline conclusion. On these grounds, we reaffirm the important distinction between palliative care prescribing and euthanasia in practice.

  • palliative care
  • euthanasia
  • end-of-life
  • clinical ethics
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors All authors conceived the response. GS, CG and RG wrote the first draft of the manuscript. All authors contributed to subsequent drafting and critical revisions. All authors approved the final version.

  • Funding GS is supported by Wellcome Trust Research Award for Health Professionals (208129/Z/17/Z).

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement This is a response article and contains no data.

  • Patient consent for publication Not required.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles